Debbie was appointed to the Cancer Research Horizons Board (formerly Cancer Research Technology) in 2015 and is on the investment committee of the Cancer Research Horizons Seed Fund. She is an Advisor in the London office of SR One and focuses on the discovery and development of novel medicines and therapeutic platforms.
Debbie brings over 17 years of experience from her accomplished career across a number of operational roles in the pharmaceutical industry. Leveraging her experience in clinical development, business development and licensing, Debbie has a track record of identifying, supporting and growing successful biotech companies. She is a respected and high profile member of the venture community in Europe with a wide ranging network to source, evaluate and shape innovative investments across multiple geographies.
Debbie is also a member of the Advisory Board of the University of Cambridge Maxwell Centre’s ‘Impulse’ programme for young entrepreneurs.